TABLE.

OVERVIEW OF FOUR CASES OF NECROBIOTIC XANTHOGRANULOMA AND TWO CASES OF ADULT-ONSET XANTHOGRANULOMA

CASE NO.	AGE/SEX	DX	ASSOCIATED SYSTEMIC DISEASE	SYMPTOMS AND SIGNS	DURATION OF SYMPTOMS AND SIGNS (MONTHS)	INVOLVED SITE	ORBITAL INVOLVEMENT	TRIAMCINOLONE DOSE	NO. OF INJECTIONS	RESPONSE	COMPLICATION	FOLLOW-UP (MONTHS)
1	60/M	NXG	None	Nodularity, discoloration, diplopia, swelling, ptosis	32.0	Bilateral	Bilateral superoanterior	40 mg	22	Improved nodularity, discoloration, ptosis	None	86
2	54/M	NXG	NHL	Nodularity, discoloration, diplopia	1.5	Bilateral	Unknown	40 mg	2	Improved nodularity	None	3
3	73/F	NXG	MGUS	Nodularity, discoloration, diplopia, proptosis, ptosis, pain	6.0	Bilateral	Left superoanterior	30 to 120 mg	9	Improved nodularity, discoloration, diplopia	None	37
4	41/M	NXG	CLL, MDS	Nodularity, discoloration, proptosis, swelling	60.0	Bilateral	Bilateral superoanterior and EOM	30 mg	1	Stable	None	96 (died of CLL)
5	34/F	AXG	Eczema	Nodularity, discoloration, proptosis	24.0	Bilateral	Bilateral superoanterior	32 to 70 mg	3	Improved all signs	None	46
6	57/F	AXG	None	Nodularity, discoloration, diplopia, proptosis, ptosis	48.0	Right	Superoanterior	40 to 90 mg	2	Improved all signs	None	30

AXG = adult-onset xanthogranuloma; CLL = chronic lymphocytic leukemia; Dx = diagnosis; EOM = extraocular muscles; MDS = myelodysplastic syndrome; MGUS = monoclonal gammopathy of uncertain significance; NHL = non-Hodgkin’s lymphoma; NXG = necrobiotic xanthogranuloma.